TRILLIUM THERAPEUTICS INC - COM NEW

CUSIP: 89620X506

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / COM NEW
Total 13F shares
77,632,016
Share change
-4,298,071
Total reported value
$1,363,417,099
Put/Call ratio
63%
Price per share
$17.56
Number of holders
175
Value change
+$133,218,058
Number of buys
121
Number of sells
71

Quarterly Holders Quick Answers

What is CUSIP 89620X506?
CUSIP 89620X506 identifies 89620X506 - TRILLIUM THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TRILLIUM THERAPEUTICS INC - COM NEW as of Q3 2021

As of 30 Sep 2021, TRILLIUM THERAPEUTICS INC - COM NEW was held by 175 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 77,632,016 shares. The largest 10 holders included BlackRock Inc., NEA Management Company, LLC, Avoro Capital Advisors LLC, EVENTIDE ASSET MANAGEMENT, LLC, Magnetar Financial LLC, Pentwater Capital Management LP, FRAZIER MANAGEMENT LLC, Omni Partners US LLC, Versor Investments LP, and GABELLI FUNDS LLC. This page lists 175 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.